Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives, and preparation method and treatment use thereof

A technology of difluorobenzenesulfonamide and methoxypyridine, which is applied in the field of medicine and can solve the problems of low selectivity and large side effects

Inactive Publication Date: 2014-05-14
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, traditional cytotoxic antitumor drugs have serious shortcomings such as low selectivity and large side effects. PI3K inhibitors can target tumor cells, which is expected to reduce the above shortcomings

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives, and preparation method and treatment use thereof
  • N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives, and preparation method and treatment use thereof
  • N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives, and preparation method and treatment use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0128] N-(5-(4-(1H-1,2,4-triazol-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)-2,4-di The preparation of fluorobenzenesulfonamide (IV, compound number 1 in the table):

[0129]

[0130] a) Preparation of 6-bromo-4-(1H-1,2,4-triazol-1-yl)quinoline (III):

[0131] Add 6-bromo-4-chloroquinoline (0.5g, 2.06mmol) and triazole (0.71g, 10.30mmol) into a 25ml single-necked bottle, dissolve in 4mL of 1,4-dioxane, and reflux at 90°C Stir and heat for 4 hours, cool to room temperature, add chloroform and saturated sodium bicarbonate solution for extraction, wash the organic layer with water and saturated brine respectively, dry over anhydrous magnesium sulfate, and evaporate to dryness under reduced pressure, 0.24 g of the solid product crystallized with ether, yield rate of 42.9%. MS (ESI) m / z: 275.16 (M+H+).

[0132] B) N-(5-(4-(1H-1,2,4-triazol-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)-2,4 - Preparation of difluorobenzenesulfonamide (IV, compound number 1 in the table):

[0133]...

Embodiment 2-3

[0135] Compounds 2 and 3 in Table 1 can be prepared from corresponding raw materials by referring to the general method for preparing the compound of Example 1.

Embodiment 4

[0137] N-(5-(4-chloroquinolin-6-yl)-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide (IV, compound number 4 in the table)

[0138]

[0139] a) Preparation of 4-chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline (HI):

[0140] Add raw material (II) (0.50g, 2.06mmol) in the 50ml eggplant-shaped bottle, dissolve with 13mL of dioxane, add biboronic acid pinacol ester (0.79g, 3.10mmol) and potassium acetate (0.81g , 8.25mmol) and palladium catalyst PdCl 2 (dppf)CH 2 Cl 2 (0.128g, 0.157mmol), heated at 90°C for 3 hours under nitrogen protection. After cooling to room temperature, the solvent was evaporated to dryness, and the resulting mixture was extracted with ethyl acetate (20 mL) and water (20 mL). The aqueous layer was extracted with a small amount of ethyl acetate (15mL×2), the organic layers were combined, dried over anhydrous sodium sulfate, and concentrated to obtain 1.15g of crude product (PH=6), which was purified by silica gel column chromatograp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine, and concretely relates to various different types substituted N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives represented by formula (1) (all groups in the formula (1) are defined in the specification. The above compounds have a good antitumor activity against a plurality of tumors comprising human lung cancer, colon cancer, liver cancer, breast cancer, cerebral astrocytoma and the like, lays a foundation for the development of antitumor medicines having the advantages of high efficiency, low toxicity and strong specificity, and has a very good exploitation value. The invention also relates to a composition containing the compounds, a preparation method of the composition, and a use of the composition in the preparation of the antitumor medicines.

Description

technical field [0001] The invention relates to the technical field of medicine, and relates to a class of various types of substituted N-(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamide derivatives, a preparation method and a composition. The present invention also relates to the use of such compounds in the preparation of therapeutic drugs for one or more of the following diseases: autoimmune diseases, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergies, asthma, pancreatitis , multiple organ failure, kidney disease, platelet aggregation, cancer, sperm motility, transplant rejection, graft rejection, and lung injury, especially cancer. These compounds exhibit good broad-spectrum inhibitory activity against various tumor cells such as human lung cancer, colon cancer, liver cancer, breast cancer, and colon cancer. Background technique [0002] Phosphatidylinositol-3-kinases (PI3K) is a member of the lipid kinase family, which can regulate c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/14C07D401/04A61K31/4709A61K31/5377A61K31/496A61P35/00A61P37/06A61P35/02
CPCC07D401/04C07D401/14A61K9/0019A61K45/06A61K9/2009A61K9/2018A61K9/2059A61K9/4858A61K31/4709A61P35/00A61P35/02A61P37/06A61K2300/00
Inventor 朱驹宋云龙韩进松陈颖吕加国周有骏
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com